4-[[3-[2-(dipropylamino)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carbonyl]-4-fluoro-phenyl]methyl]-2H-phthalazin-1-one

ID: ALA5177603

PubChem CID: 168276216

Max Phase: Preclinical

Molecular Formula: C29H31FN6O2

Molecular Weight: 514.61

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN(CCC)c1ncc2c(n1)CCN(C(=O)c1cc(Cc3n[nH]c(=O)c4ccccc34)ccc1F)C2

Standard InChI:  InChI=1S/C29H31FN6O2/c1-3-12-35(13-4-2)29-31-17-20-18-36(14-11-25(20)32-29)28(38)23-15-19(9-10-24(23)30)16-26-21-7-5-6-8-22(21)27(37)34-33-26/h5-10,15,17H,3-4,11-14,16,18H2,1-2H3,(H,34,37)

Standard InChI Key:  LRWSEVGBTWOZDN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   -5.7145    1.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9999    2.2671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2881    1.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2881    1.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9981    0.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7145    1.0263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5734    2.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588    1.8551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588    1.0300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5734    0.6173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5734    3.0929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5734   -0.2077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588   -0.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1440   -0.2079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4319   -0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4319   -1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1421   -1.8573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8588   -1.4490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7171   -1.8579    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7171   -0.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7171    0.6178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0026   -0.6199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119   -0.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4266   -0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4266   -1.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119   -1.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0026   -1.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1393   -0.2091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8541   -0.6215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8560   -1.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1443   -1.8592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5706   -1.8552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2852   -1.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9999   -1.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2852   -3.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5706   -2.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7145   -1.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9999   -2.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  4 10  1  0
  7 11  2  0
 10 12  1  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 16 19  1  0
 15 20  1  0
 20 21  2  0
 20 22  1  0
 23 22  1  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  1  0
 22 27  1  0
 24 28  1  0
 29 28  2  0
 30 29  1  0
 31 30  2  0
 25 31  1  0
 30 32  1  0
 33 32  1  0
 34 33  1  0
 36 35  1  0
 32 36  1  0
 34 37  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5177603

    ---

Associated Targets(Human)

HCC1937 (423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MX1 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.61Molecular Weight (Monoisotopic): 514.2493AlogP: 4.27#Rotatable Bonds: 8
Polar Surface Area: 95.08Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.96CX Basic pKa: 2.61CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.38Np Likeness Score: -1.71

References

1. Lin S, Zhang X, Yu Z, Huang X, Xu J, Liu Y, Wu L..  (2022)  Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers.,  61  [PMID:35393219] [10.1016/j.bmc.2022.116739]

Source